 comparison lhrh analogu zoladex orchiectomi patient metastat prostat carcinoma between novemb februari patient metastat prostat carcinoma multicentr trial unit kingdom republ ireland lhrh analogu zoladex ici pharmaceut plc day orchiectomi treatment effect serum testosteron concentr castrat rang equival subject object respons rate time treatment failur median follow-up year differ overal surviv zoladex effect medic altern patient metastat diseas